Synthesis and Biological Activity of 6-Selenocaffeine: Potential Modulator of Chemotherapeutic Drugs in Breast Cancer Cells
We report the development of a new microwave-based synthetic methodology mediated by Woollins’ reagent that allowed an efficient conversion of caffeine into 6-selenocaffeine. A preliminary evaluation on the modulation of antioxidant activity upon selenation of caffeine, using the DPPH assay, indicat...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-05-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/18/5/5251 |
id |
doaj-3a0474ceb2c145adb39a74421f51e0f5 |
---|---|
record_format |
Article |
spelling |
doaj-3a0474ceb2c145adb39a74421f51e0f52020-11-25T00:08:21ZengMDPI AGMolecules1420-30492013-05-011855251526410.3390/molecules18055251Synthesis and Biological Activity of 6-Selenocaffeine: Potential Modulator of Chemotherapeutic Drugs in Breast Cancer CellsInês L. MartinsJoana P. MirandaNuno G. OliveiraAna S. FernandesSandrina GonçalvesAlexandra M. M. AntunesWe report the development of a new microwave-based synthetic methodology mediated by Woollins’ reagent that allowed an efficient conversion of caffeine into 6-selenocaffeine. A preliminary evaluation on the modulation of antioxidant activity upon selenation of caffeine, using the DPPH assay, indicated a mild antioxidant activity for 6-selenocaffeine, contrasting with caffeine, that exhibited no antioxidant activity under the same experimental conditions. Interestingly, whereas 6-selenocaffeine has revealed to have a low cytotoxic potential in both MCF10A and MCF-7 breast cells (24 h, up to 100 µM, MTT assay), a differential effect was observed when used in combination with the anticancer agents doxorubicin and oxaliplatin in MCF-7 breast cancer cells. The co-treatment of doxorubicin (1 µM) and 6-selenocaffeine (100 µM) resulted in a slight decrease in cellular viability when compared to doxorubicin (1 µM) alone. Conversely, the seleno-caffeine derivative at the same concentration markedly increased the viability of oxaliplatin (100 µM)-treated cells (p < 0.01). Overall, this work highlights an emerging methodology to synthesize organoselenium compounds and points out the differential roles of 6-selenocaffeine in the modulation of the cytotoxicity of anticancer agents.http://www.mdpi.com/1420-3049/18/5/5251organoselenium compoundscaffeinemodulator of the cytoxicityoxaliplatindoxorubicincancer therapy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Inês L. Martins Joana P. Miranda Nuno G. Oliveira Ana S. Fernandes Sandrina Gonçalves Alexandra M. M. Antunes |
spellingShingle |
Inês L. Martins Joana P. Miranda Nuno G. Oliveira Ana S. Fernandes Sandrina Gonçalves Alexandra M. M. Antunes Synthesis and Biological Activity of 6-Selenocaffeine: Potential Modulator of Chemotherapeutic Drugs in Breast Cancer Cells Molecules organoselenium compounds caffeine modulator of the cytoxicity oxaliplatin doxorubicin cancer therapy |
author_facet |
Inês L. Martins Joana P. Miranda Nuno G. Oliveira Ana S. Fernandes Sandrina Gonçalves Alexandra M. M. Antunes |
author_sort |
Inês L. Martins |
title |
Synthesis and Biological Activity of 6-Selenocaffeine: Potential Modulator of Chemotherapeutic Drugs in Breast Cancer Cells |
title_short |
Synthesis and Biological Activity of 6-Selenocaffeine: Potential Modulator of Chemotherapeutic Drugs in Breast Cancer Cells |
title_full |
Synthesis and Biological Activity of 6-Selenocaffeine: Potential Modulator of Chemotherapeutic Drugs in Breast Cancer Cells |
title_fullStr |
Synthesis and Biological Activity of 6-Selenocaffeine: Potential Modulator of Chemotherapeutic Drugs in Breast Cancer Cells |
title_full_unstemmed |
Synthesis and Biological Activity of 6-Selenocaffeine: Potential Modulator of Chemotherapeutic Drugs in Breast Cancer Cells |
title_sort |
synthesis and biological activity of 6-selenocaffeine: potential modulator of chemotherapeutic drugs in breast cancer cells |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2013-05-01 |
description |
We report the development of a new microwave-based synthetic methodology mediated by Woollins’ reagent that allowed an efficient conversion of caffeine into 6-selenocaffeine. A preliminary evaluation on the modulation of antioxidant activity upon selenation of caffeine, using the DPPH assay, indicated a mild antioxidant activity for 6-selenocaffeine, contrasting with caffeine, that exhibited no antioxidant activity under the same experimental conditions. Interestingly, whereas 6-selenocaffeine has revealed to have a low cytotoxic potential in both MCF10A and MCF-7 breast cells (24 h, up to 100 µM, MTT assay), a differential effect was observed when used in combination with the anticancer agents doxorubicin and oxaliplatin in MCF-7 breast cancer cells. The co-treatment of doxorubicin (1 µM) and 6-selenocaffeine (100 µM) resulted in a slight decrease in cellular viability when compared to doxorubicin (1 µM) alone. Conversely, the seleno-caffeine derivative at the same concentration markedly increased the viability of oxaliplatin (100 µM)-treated cells (p < 0.01). Overall, this work highlights an emerging methodology to synthesize organoselenium compounds and points out the differential roles of 6-selenocaffeine in the modulation of the cytotoxicity of anticancer agents. |
topic |
organoselenium compounds caffeine modulator of the cytoxicity oxaliplatin doxorubicin cancer therapy |
url |
http://www.mdpi.com/1420-3049/18/5/5251 |
work_keys_str_mv |
AT ineslmartins synthesisandbiologicalactivityof6selenocaffeinepotentialmodulatorofchemotherapeuticdrugsinbreastcancercells AT joanapmiranda synthesisandbiologicalactivityof6selenocaffeinepotentialmodulatorofchemotherapeuticdrugsinbreastcancercells AT nunogoliveira synthesisandbiologicalactivityof6selenocaffeinepotentialmodulatorofchemotherapeuticdrugsinbreastcancercells AT anasfernandes synthesisandbiologicalactivityof6selenocaffeinepotentialmodulatorofchemotherapeuticdrugsinbreastcancercells AT sandrinagoncalves synthesisandbiologicalactivityof6selenocaffeinepotentialmodulatorofchemotherapeuticdrugsinbreastcancercells AT alexandrammantunes synthesisandbiologicalactivityof6selenocaffeinepotentialmodulatorofchemotherapeuticdrugsinbreastcancercells |
_version_ |
1725415592853241856 |